Skip to main content

May 2024, Vol 14, No 5

State legislators have been focusing on reducing drug costs deemed “unaffordable” for patients via prescription drug affordability boards (PDABs). However, PDABs allow government-appointed board members to make critical medical decisions on pricing and access to prescription drugs for a state’s patients—without consulting medical providers or individual patient information. It is critical that we advocate for our patients to ensure that they receive medically necessary medications. Read More ›

Despite ranking among the top 6 wealthiest economies in the world per capita, the United States still has sizable health disparities among its citizens, which are rooted in social, economic, and environmental factors. A comprehensive local approach was developed at Carolina Blood and Cancer Care Associates to include support from all segments of the health ecosystem. Read More ›

Healthcare organizations need policies and procedures so that employees are clear about their roles, and the organization remains in compliance with federal, state, and local regulations. Practice managers and other healthcare leaders can focus on 5 primary areas to assess whether their policies and procedures cover foundational needs. Read More ›

In this contribution from the Practice Management Institute, Ms Hailey provides 5 effective strategies for managing reduced reimbursements, denied claims, or reimbursement delays drawn from guidelines issued by healthcare finance and insurance experts. Read More ›

The acceleration of technology in the healthcare sector has been helpful in streamlining many aspects of day-to-day operations, but new innovations continue apace, including customer relationship management software, business intelligence tools, artificial intelligence, and updated electronic medical records and telehealth systems. Read More ›

The Centers for Medicare & Medicaid Services recently released updates to the Healthcare Common Procedure Coding System Level II file, which include multiple new codes for oncology drugs. With so many new drugs on the list this year, providers may face challenges in determining when and how to report discarded drugs. Read More ›